Latest News & Features
Europe
The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s potential, says Graeme Moore of Mewburn Ellis. 31 October 2024
Americas
UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering haemophilia B therapies in the US, Canada and UK 29 October 2024
Europe
Former head of life sciences at Gowling, joins Cooley’s London office as a partner | Brings expertise in cross-border licensing and collaboration deals in the pharmaceutical, biotech, and medical device sectors. 29 October 2024
Americas
A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not apply to its current products. 29 October 2024
Americas
Regeneron loses bid to block Eylea copy at US appeals court | Biotech says decision ‘not the final word’ in litigation 24 October 2024
Americas
Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America. 24 October 2024
Careers
Keo McKenzie re-joins firm’s Washington, DC office, bringing over a decade of experience in AI, healthcare, and technology law. 24 October 2024
Americas
10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen. 22 October 2024
Americas
Columbia court backs FDA approval of Entresto generic I Novartis appealing August ruling in Delaware that denied injunction. 22 October 2024
Americas
In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen. 22 October 2024